Order Article Reprints

Gaidano V, Houshmand M, Vitale N, Carrà G, Morotti A, Tenace V, Rapelli S, Sainas S, Pippione AC, Giorgis M, et al. The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia. Cancers. 2021; 13(5):1003. https://doi.org/10.3390/cancers13051003

Gaidano, Valentina, Mohammad Houshmand, Nicoletta Vitale, Giovanna Carrà, Alessandro Morotti, Valerio Tenace, Stefania Rapelli, Stefano Sainas, Agnese Chiara Pippione, Marta Giorgis, and et al. 2021. "The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia" Cancers 13, no. 5: 1003. https://doi.org/10.3390/cancers13051003

Gaidano, V., Houshmand, M., Vitale, N., Carrà, G., Morotti, A., Tenace, V., Rapelli, S., Sainas, S., Pippione, A. C., Giorgis, M., Boschi, D., Lolli, M. L., Cilloni, D., Cignetti, A., Saglio, G., & Circosta, P. (2021). The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia. Cancers, 13(5), 1003. https://doi.org/10.3390/cancers13051003